Silicon Laboratories (SLAB) Cash & Equivalents (2009 - 2026)

Silicon Laboratories has reported Cash & Equivalents for 18 years, with the latest figure at $383.1 million in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents rose 17.92% year-over-year to $383.1 million; the trailing twelve-month figure through Apr 2026 stood at $383.1 million (up 17.92% YoY), and the FY2026 full-year result was $364.2 million, up 29.34% from the prior year.
• Cash & Equivalents for Q2 2026 stood at $383.1 million, up from $364.2 million in the prior quarter.
• The five-year high for Cash & Equivalents was $1.1 billion in Q1 2022, with the low at $159.9 million in Q3 2023.
• Average Cash & Equivalents over 5 years is $411.8 million, with a median of $333.1 million recorded in 2025.
• Year-over-year, Cash & Equivalents soared 430.1% in 2022 and tumbled 73.27% in 2024.
• Tracing SLAB's Cash & Equivalents over 5 years: stood at $499.9 million in 2022, then plunged by 54.49% to $227.5 million in 2023, then gained by 23.78% to $281.6 million in 2024, then increased by 21.23% to $341.4 million in 2025, then increased by 12.21% to $383.1 million in 2026.
• The last three Cash & Equivalents figures came in at $383.1 million (Q2 2026), $364.2 million (Q1 2026), and $341.4 million (Q4 2025), per Business Quant data.

Peer Comparison